Viemed Healthcare, Inc. (NASDAQ:VMD) Sees Significant Growth in Short Interest

Viemed Healthcare, Inc. (NASDAQ:VMD - Get Free Report) was the target of a significant growth in short interest in March. As of March 31st, there was short interest totalling 398,300 shares, a growth of 25.2% from the March 15th total of 318,100 shares. Approximately 1.2% of the shares of the company are sold short. Based on an average daily volume of 114,100 shares, the short-interest ratio is presently 3.5 days.

Hedge Funds Weigh In On Viemed Healthcare

A number of hedge funds have recently modified their holdings of the business. Barclays PLC boosted its stake in Viemed Healthcare by 342.3% during the 3rd quarter. Barclays PLC now owns 53,439 shares of the company's stock worth $392,000 after purchasing an additional 41,358 shares during the period. JPMorgan Chase & Co. grew its holdings in shares of Viemed Healthcare by 151.7% during the third quarter. JPMorgan Chase & Co. now owns 98,798 shares of the company's stock worth $724,000 after buying an additional 59,538 shares during the last quarter. SG Americas Securities LLC increased its position in Viemed Healthcare by 193.1% in the 4th quarter. SG Americas Securities LLC now owns 35,579 shares of the company's stock valued at $285,000 after acquiring an additional 23,442 shares during the period. R Squared Ltd acquired a new stake in Viemed Healthcare during the 4th quarter worth approximately $41,000. Finally, Rhumbline Advisers grew its stake in shares of Viemed Healthcare by 15.5% in the 4th quarter. Rhumbline Advisers now owns 46,836 shares of the company's stock valued at $376,000 after purchasing an additional 6,275 shares during the last quarter. 74.24% of the stock is currently owned by hedge funds and other institutional investors.

Viemed Healthcare Stock Performance

Shares of NASDAQ VMD traded down $0.02 during trading hours on Friday, reaching $6.97. The stock had a trading volume of 86,222 shares, compared to its average volume of 138,275. The firm has a 50-day moving average of $7.24 and a 200-day moving average of $8.06. The firm has a market cap of $275.27 million, a price-to-earnings ratio of 25.80 and a beta of 1.64. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03. Viemed Healthcare has a fifty-two week low of $6.21 and a fifty-two week high of $9.81.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.